FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Planning finances for a growing family requires careful consideration. Learn expert tips to manage your budget effectively during this transition.
13,820 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
A CFO diverted $35 million into a private crypto venture, only to see most of it vanish in the Terra collapse. This p...
A viral Substack piece by a former EMT triggered rapid stock declines as AI fears spread. This article explains what ...
Oracle’s Stargate initiative in Texas stalls amid financing questions and evolving AI compute needs, rattling investo...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
A notable fund recently reported a substantial exit in a popular beauty stock. We break down what this move could sig...
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
Palantir Technologies stock popped on a rally driven by legal news and AI momentum. This guide explains what happened...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
A Wayfair founder sold shares worth about $2.1 million in February 2026. This article breaks down what insider sellin...
Joby Aviation has faced a rough start to 2026 after a big rally in 2025. This guide explains whether the stock is rig...
When geopolitics roils markets, the duration of the shock matters most. This week, investors should focus on how long...